Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic reviewSilvano Adami, Luca Idolazzi, Maurizio Rossini
Minerva Medica|July 22, 2016
Vitamin D: not just bone, but also immunityDavide Gatti, Luca Idolazzi, Angelo Fassio
Frontiers in Medicine|November 16, 2020
Recent Advances in Imaging for Diagnosis, Monitoring, and Prognosis of Psoriatic ArthritisAngelo Fassio, Peter Matzneller, Luca Idolazzi
Frontiers in Medicine|February 6, 2015
Management of moderate to severe psoriasis in patients with metabolic comorbiditiesPaolo Gisondi, Arturo Galvan, Luca Idolazzi, et al.
Rheumatology and Therapy|April 20, 2020
Psoriatic Arthritis and Diabetes Mellitus: A Narrative ReviewGiacomo Dal Bello, Paolo Gisondi, Luca Idolazzi, et al.
The Journal of Rheumatology. Supplement|November 3, 2015
Concept of Remission in Chronic Plaque PsoriasisPaolo Gisondi, Marco Di Mercurio, Luca Idolazzi, et al.
Bone Research|August 15, 2015
Osteoporosis Treatment: When to Discontinue and When to Re-startSilvano Adami, Luca Idolazzi, Elena Fracassi, et al.
Annals of the Rheumatic Diseases|June 19, 2021
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasisPaolo Gisondi, Francesco Bellinato, Giovanni Targher, et al.
Therapeutics and Clinical Risk Management|April 17, 2013
Clinical development of neridronate: potential for new applicationsDavide Gatti, Maurizio Rossini, Ombretta Viapiana, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2009
Neridronic acid for the treatment of bone metabolic diseasesDavide Gatti, Ombretta Viapiana, Luca Idolazzi, et al.
Pageof 12